Certified by Founder Lodge
BioLoomics, Inc.
United States - Boulder, CO
START UP
1 Disclosed Funding Rounds $8,700,000
0 Participating Investments
-
Founded date
2019
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
BioLoomics is a preclinical stage biotechnology company leveraging directed evolution of antibodies in human cells to create target degrading antibodies. Our proprietary tech combines single-
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| September, 20 ,2023 | Seed | $8,700,000 |
Horizons Ventures
TECHU
Boom Capital
BoxOne Ventures
Enveda Biosciences
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Acurion, Inc. | $4,300,000 | (Apr 3, 2026)
EnerVenue | $300,000,000 | (Apr 3, 2026)
Monarch Quantum | $55,000,000 | (Apr 3, 2026)
Numos | $4,250,000 | (Apr 3, 2026)
Gander Robotics | $1,100,000 | (Apr 3, 2026)
